 |
市場調查報告書
商品編碼
1411680
登革熱檢測市場：按類型、組件和最終用戶分類 - 2024-2030 年全球預測Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030 |
||||||
價格
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年登革熱檢測市場規模為4.9978億美元，2024年將達5.2702億美元，2030年將達7.3769億美元，複合年成長率為5.71%。
登革熱檢測的全球市場
| 主要市場統計 | |
|---|---|
| 基準年[2023] | 4.9978 億美元 |
| 預測年份 [2024] | 52702萬美元 |
| 預測年份 [2030] | 73769萬美元 |
| 複合年成長率（%） | 5.71% |
FPNV定位矩陣
FPNV定位矩陣對於評估登革熱偵測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。
市場佔有率分析
市場佔有率分析是一種綜合工具，可以對登革熱測試市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。
該報告對以下幾個方面提供了寶貴的見解：
1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。
2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。
3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。
本報告解決了以下關鍵問題：
1-登革熱檢測市場的市場規模和預測是多少？
2-在登革熱檢測市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？
3-登革熱檢測市場的技術趨勢和法律規範是什麼？
4-登革熱檢測市場主要供應商的市場佔有率是多少？
5-進入登革熱檢測市場的適當型態和策略手段是什麼？
目錄
第1章 前言
第2章調查方法
第3章執行摘要
第4章市場概況
第5章市場洞察
- 市場動態
- 促進因素
- 人群中登革熱感染疾病的發生率增加
- 擴大政府努力提高醫療保健意識
- 增加每個國家的醫療基礎設施和支出
- 抑制因素
- 診斷套件和測試相關的高成本
- 機會
- 強力研發先進登革熱檢測套件
- 消除蚊媒登革熱的新測試模型的演變
- 任務
- 對現有測試方法的有效性和有效性的擔憂
- 促進因素
- 市場區隔分析
- 市場趨勢分析
- 高通膨的累積效應
- 波特五力分析
- 價值鍊和關鍵路徑分析
- 法律規範
第6章登革熱檢測市場：按類型
- 登革熱 IgG/IgM 快速檢測
- 基於 ELISA 的測試
- 即時RT-PCR檢測
第7章登革熱檢測市場：依組成部分
- 器材與設備
- 實驗耗材
- 軟體和資料管理解決方案
第8章登革熱檢測市場：依最終用戶分類
- 診斷中心
- 醫院
- 調查機構
第9章 北美、南美登革熱檢測市場
- 阿根廷
- 巴西
- 加拿大
- 墨西哥
- 美國
第10章 亞太地區登革熱檢測市場
- 澳洲
- 中國
- 印度
- 印尼
- 日本
- 馬來西亞
- 菲律賓
- 新加坡
- 韓國
- 台灣
- 泰國
- 越南
第11章 歐洲、中東和非洲登革熱檢測市場
- 丹麥
- 埃及
- 芬蘭
- 法國
- 德國
- 以色列
- 義大利
- 荷蘭
- 奈及利亞
- 挪威
- 波蘭
- 卡達
- 俄羅斯
- 沙烏地阿拉伯
- 南非
- 西班牙
- 瑞典
- 瑞士
- 土耳其
- 阿拉伯聯合大公國
- 英國
第12章競爭形勢
- FPNV定位矩陣
- 市場佔有率分析：主要企業
- 主要企業競爭情境分析
第13章競爭產品組合
- 主要公司簡介
- Abbott Laboratories
- Abnova Corporation
- Biogenix Inc. Pvt. Ltd.
- Biolab Diagnostics{I}Pvt. Ltd.
- Biopanda Reagents Ltd.
- Certest Biotec, SL
- DiaSorin SpA
- EUROIMMUN Medizinische Labordiagnostika AG
- F. Hoffmann-La Roche Ltd.
- Getein Biotech, Inc.
- InBios International, Inc.
- Intec Products, Inc.
- Lexicare Pharma Pvt. Ltd.
- NovaTec Immundiagnostica GmbH
- OriGene Technologies, Inc.
- Quest Diagnostics
- Reckon Diagnostics Pvt. Ltd.
- Reliable Pro-detect Biomedicals Pvt. Ltd.
- Saheb Pharmaceuticals LLP
- Sri Pharmacare
- Thermo Fisher Scientific Inc.
- 主要產品系列
第14章附錄
- 討論指南
- 關於許可證和定價
Product Code: MRR-69324464D112
[181 Pages Report] The Dengue Testing Market size was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030.
Global Dengue Testing Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 499.78 million |
| Estimated Year [2024] | USD 527.02 million |
| Forecast Year [2030] | USD 737.69 million |
| CAGR (%) | 5.71% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Dengue Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dengue Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Dengue Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., Biopanda Reagents Ltd., Certest Biotec, S.L., DiaSorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Reliable Pro-detect Biomedicals Pvt. Ltd., Saheb Pharmaceuticals LLP, Sri Pharmacare, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Dengue Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Dengue IgG/IgM Rapid Test
- ELISA-based Test
- Real-Time RT-PCR Test
- Component
- Instruments & Equipments
- Laboratory Consumables
- Software & Data Management Solutions
- End-User
- Diagnostic Centers
- Hospitals
- Research Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Dengue Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dengue Testing Market?
3. What are the technology trends and regulatory frameworks in the Dengue Testing Market?
4. What is the market share of the leading vendors in the Dengue Testing Market?
5. Which modes and strategic moves are suitable for entering the Dengue Testing Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Dengue Testing Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing incidences of dengue infections among population
- 5.1.1.2. Growing government initiatives promoting healthcare awareness
- 5.1.1.3. Rise in healthcare infrastructure and spendings across economies
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with diagnostic kits and tests
- 5.1.3. Opportunities
- 5.1.3.1. Robust research and development of advanced dengue detection kits
- 5.1.3.2. Evolution of new testing model to swat mosquito-borne dengue fever
- 5.1.4. Challenges
- 5.1.4.1. Concerns over efficacy and effectiveness of existing testing methods
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Dengue Testing Market, by Type
- 6.1. Introduction
- 6.2. Dengue IgG/IgM Rapid Test
- 6.3. ELISA-based Test
- 6.4. Real-Time RT-PCR Test
7. Dengue Testing Market, by Component
- 7.1. Introduction
- 7.2. Instruments & Equipments
- 7.3. Laboratory Consumables
- 7.4. Software & Data Management Solutions
8. Dengue Testing Market, by End-User
- 8.1. Introduction
- 8.2. Diagnostic Centers
- 8.3. Hospitals
- 8.4. Research Institutes
9. Americas Dengue Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Dengue Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Dengue Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Abnova Corporation
- 13.1.3. Biogenix Inc. Pvt. Ltd.
- 13.1.4. Biolab Diagnostics {I}Pvt. Ltd.
- 13.1.5. Biopanda Reagents Ltd.
- 13.1.6. Certest Biotec, S.L.
- 13.1.7. DiaSorin S.p.A.
- 13.1.8. EUROIMMUN Medizinische Labordiagnostika AG
- 13.1.9. F. Hoffmann-La Roche Ltd.
- 13.1.10. Getein Biotech, Inc.
- 13.1.11. InBios International, Inc.
- 13.1.12. Intec Products, Inc.
- 13.1.13. Lexicare Pharma Pvt. Ltd.
- 13.1.14. NovaTec Immundiagnostica GmbH
- 13.1.15. OriGene Technologies, Inc.
- 13.1.16. Quest Diagnostics
- 13.1.17. Reckon Diagnostics Pvt. Ltd.
- 13.1.18. Reliable Pro-detect Biomedicals Pvt. Ltd.
- 13.1.19. Saheb Pharmaceuticals LLP
- 13.1.20. Sri Pharmacare
- 13.1.21. Thermo Fisher Scientific Inc.
- 13.2. Key Product Portfolio
14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
LIST OF FIGURES
- FIGURE 1. DENGUE TESTING MARKET RESEARCH PROCESS
- FIGURE 2. DENGUE TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DENGUE TESTING MARKET DYNAMICS
- FIGURE 7. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
- FIGURE 10. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. DENGUE TESTING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 6. DENGUE TESTING MARKET SIZE, BY DENGUE IGG/IGM RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. DENGUE TESTING MARKET SIZE, BY ELISA-BASED TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. DENGUE TESTING MARKET SIZE, BY REAL-TIME RT-PCR TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 10. DENGUE TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. DENGUE TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. DENGUE TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 14. DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 27. CANADA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 28. CANADA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 29. CANADA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. CHINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 45. CHINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 46. CHINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. INDIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. INDIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 49. INDIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. ITALY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 100. ITALY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 101. ITALY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 111. POLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 112. POLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 113. POLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. QATAR DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 115. QATAR DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 116. QATAR DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 145. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 146. DENGUE TESTING MARKET LICENSE & PRICING
